Arbutus Biopharma Corp (NASDAQ:ABUS)

1.90
Delayed Data
As of Nov 29
 +0.05 / +2.70%
Today’s Change
1.69
Today|||52-Week Range
3.15
-18.45%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$311.9M

Company Description

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the Hepatitis B virus, SARS-CoV-2, and other coronaviruses. The company was founded on October 6, 2005 and is headquartered in Warminster, PA.

Contact Information

Arbutus Biopharma Corp.
701 Veterans Circle
Warminster Pennsylvania 18974
P:(267) 469-0914
Investor Relations:
(215) 206-1822

Employees

Shareholders

Other institutional31.06%
Individual stakeholders12.15%
Mutual fund holders12.02%

Top Executives

William H. CollierPresident, Chief Executive Officer & Director
Michael J. McElhaughChief Operating Officer
David C. HastingsChief Financial & Accounting Officer
Michael J. SofiaChief Scientific Officer
Karen SimsChief Medical Officer